Effect of TyG Index on Outcomes of Radical Prostatectomy
NCT ID: NCT03447028
Last Updated: 2018-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2007-01-01
2012-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Plasma Neutrophil Gelatinase - Associated Lipocalin (NGAL) Levels
NCT03607279
Evaluation of Kidney Damage Using NGAL Measurements
NCT06274125
PERIOPERATIVE MYOCARDIAL DAMAGE IN ROBOT-ASSISTED SURGERY
NCT06502340
Retzius-sparing Technique in Robotic-assisted Radical Prostatectomy
NCT05224024
Is There a Relationship Between Serum Sodium Level and Mean Platelet Volume (MPV) Value
NCT03276234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* presence of endocrinological disease,
* history of bariatric surgery,
* missing data and patients with uncontrolled follow-up
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Recep Tayyip Erdogan University Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mustafa Ozan HORSANALI
Urologist
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Recepteutrh
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.